HEMIMARCHE: Impact of Prolonged Physical Therapy on Gait Performance of Chronic Phase Stroke Patients

Sponsor
Centre Hospitalier Universitaire de Saint Etienne (Other)
Overall Status
Terminated
CT.gov ID
NCT00658710
Collaborator
Ministry of Health, France (Other)
70
5
2
54
14
0.3

Study Details

Study Description

Brief Summary

The aim of this multi-center, randomized controlled study is to acquire and compare information on gait performance in patients with chronic hemiplegia (six months to two years post-stroke) who either continue to attend two physical therapy sessions per week for two months or who stop physical therapy sessions for two months.Following the initial screening, subjects will be randomized into two groups: one who continues attending two physical therapy sessions per week for two months, or the other one who stops physical therapy sessions for two months. Before and after those two months, a 3 days recording will be made using an ambulatory system called TRIDENT.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: physical therapy sessions
N/A

Detailed Description

The aim of this multi-center, randomized controlled study is to acquire and compare information on gait performance in patients with chronic hemiplegia (six months to two years post-stroke) who either continue to attend two physical therapy sessions per week for two months or who stop physical therapy sessions for two months. This will permit us 1) to assess the efficacy of continuing physical therapy sessions during the chronic phase of post-stroke hemiplegia, 2) to investigate whether the effects of physical therapy in these patients gradually decreases during the period of six months to two years post-stroke, and 3) to model the relationship between standard measures of gait performance (speed, endurance, balance, use of technical aids…) with other multidimensional covariates: social and environmental factors (type of housing, presence of a third person,…), cognitive factors (cognitive disorders associated) and thymic factors (anxiety, depression) and 4) to assess the costs associated with the physical therapy care of chronic-phase stroke patients .

Study Design

Study Type:
Interventional
Actual Enrollment :
70 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Impact of Prolonged Physical Therapy on Gait Performance of Chronic Phase Stroke Patients
Study Start Date :
Jun 1, 2008
Actual Primary Completion Date :
Dec 1, 2012
Actual Study Completion Date :
Dec 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: 1

patients who continue physical therapy sessions during two months.

Behavioral: physical therapy sessions
two physical therapy sessions per week for two months

No Intervention: 2

patients who stop physical therapy sessions during two months

Outcome Measures

Primary Outcome Measures

  1. the average number of steps per day recorded over 3 days in an outpatient setting [day 3 and then 6 months later]

Secondary Outcome Measures

  1. the scores to the scales (the 6 minutes walking test, the Wade's test, the Rivermead Mobility Index Score, the Barthel Index Score) [day 0 and then day 55]

  2. for the medico-economic study, the direct medical and non-medical costs associated with physical therapy of chronic stroke patients [6 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients must be aged 18 to 75 years, with a first ischemic or hemorrhagic stroke at least six months ago and no longer than two years ago, without subsequent stroke. It must have caused initially complete hemiplegia of the right or left hemibody, but they must be able of walk alone with or without technical assistance over a distance of at least 10 meters They must be able change direction too.

  • Finally, they must have a Functional Ambulation Classification (FAC) score between 4 and 6 during the inclusion.

Exclusion Criteria:
  • We will exclude patients with a neurological history other than a stroke, a psychiatric illness, or an associated debilitating disease.

  • They must not have an associated cerebella syndrome or a clinical brainstem attack.

  • We will refuse patients who are pregnant, who have not signed the written consent, and who aren't entitled to a social security scheme.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Centre Régional de Réeducation et de Réadaptation Fonctionnelle Angers France 49103
2 Groupe hospitalier Pellegrin CHU Bordeaux Bordeaux France 33076
3 Hôpital J. Rebeyrol Limoges France 87042
4 Institut Régional de médecine physique et de Réadaptation Nancy France 54042
5 CHU de St Etienne St Etienne France 42055

Sponsors and Collaborators

  • Centre Hospitalier Universitaire de Saint Etienne
  • Ministry of Health, France

Investigators

  • Principal Investigator: Pascal Giraux, MD, CHU ST Etienne

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier Universitaire de Saint Etienne
ClinicalTrials.gov Identifier:
NCT00658710
Other Study ID Numbers:
  • 0701040
  • 2007-A00747-46
First Posted:
Apr 15, 2008
Last Update Posted:
Nov 7, 2013
Last Verified:
Nov 1, 2013
Keywords provided by Centre Hospitalier Universitaire de Saint Etienne
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 7, 2013